Novocure is a private oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Switzerland and Japan and a research center in Haifa, Israel

Novocure is an overnight success story fourteen years in the making. Since 2000, the company has grown from one inspired man running experiments in his basement lab to the multinational commercial business it is today.
Type
Public
HQ
Saint Helier, JE
Founded
2000
Size (employees)
318 (est)+64%
NovoCure was founded in 2000 and is headquartered in Saint Helier, JE

Key People at NovoCure

David N.

David N.

General Manager Europe
Bill Burke

Bill Burke

Global Head HR
Laura Benson

Laura Benson

Vice President Medical Affairs
Moshe  Giladi

Moshe Giladi

Head of preclinical research

NovoCure Office Locations

NovoCure has offices in Saint Helier, Dover, Seattle, New Brunswick and in 33 other locations
Saint Helier, JE
Seattle, US
New Brunswick, US
Harrisburg, US
Tampa, US
Dayton, US
Munich, DE
Phoenix, US
Tacoma, US
Atlanta, US
Denver, US
Jersey City, US
Charlotte, US
Dallas, US
New York, US
Chiyoda-ku, JP
Root, CH
Portsmouth, US
Haifa, IL
Haifa, IL

NovoCure Metrics

NovoCure Summary

Market capitalization

$668 M

Closing share price

$7.6
NovoCure's current market capitalization is $668 M.

NovoCure Market Value History

NovoCure Online Presence

NovoCure Company Life

You may also be interested in